ALT5 Sigma to Exhibit at Money20/20 October 27-30, 2024
ALT5 Sigma (NASDAQ:ALTS) announced its participation in the upcoming Money20/20 Las Vegas conference from October 27-30, 2024. The company will exhibit at booth #11713 at The Venetian Resort, providing product demonstrations and solutions to over 12,000 attendees. Money20/20 USA is the largest gathering of the global money ecosystem, including banks, payments, tech, startups, and fintech. ALT5 Sigma's CRO Vay Tham highlighted the company's growing volumes in crypto payments, positioning them as an innovator in the payments ecosystem.
ALT5 Sigma (NASDAQ:ALTS) ha annunciato la sua partecipazione alla prossima conferenza Money20/20 di Las Vegas che si svolgerà dal 27 al 30 ottobre 2024. L'azienda esporrà allo stand n. 11713 presso The Venetian Resort, fornendo dimostrazioni di prodotto e soluzioni a oltre 12.000 partecipanti. Money20/20 USA è il più grande incontro dell'ecosistema globale del denaro, che include banche, pagamenti, tecnologia, startup e fintech. Il CRO di ALT5 Sigma, Vay Tham, ha sottolineato l'aumento dei volumi nei pagamenti in criptovaluta, posizionando l'azienda come innovatrice nell'ecosistema dei pagamenti.
ALT5 Sigma (NASDAQ:ALTS) anunció su participación en la próxima conferencia Money20/20 de Las Vegas, que se llevará a cabo del 27 al 30 de octubre de 2024. La empresa exhibirá en el stand n.º 11713 en The Venetian Resort, ofreciendo demostraciones de productos y soluciones a más de 12,000 asistentes. Money20/20 USA es la reunión más grande del ecosistema global del dinero, que incluye bancos, pagos, tecnología, startups y fintech. El CRO de ALT5 Sigma, Vay Tham, destacó el crecimiento de los volúmenes en pagos de criptomonedas, posicionando a la empresa como innovadora en el ecosistema de pagos.
ALT5 Sigma (NASDAQ:ALTS)는 2024년 10월 27일부터 30일까지 열리는 라스베가스 Money20/20 컨퍼런스에 참여한다고 발표했습니다. 회사는 The Venetian Resort의 부스 #11713에서 제품 시연과 솔루션을 제공하며, 12,000명 이상의 참석자를 맞이할 예정입니다. Money20/20 USA는 은행, 결제, 기술, 스타트업 및 핀테크를 포함한 글로벌 돈 에코시스템의 가장 큰 모임입니다. ALT5 Sigma의 CRO Vay Tham은 암호화폐 결제의 증가하는 규모를 강조하며, 회사를 결제 생태계의 혁신자로 자리매김했습니다.
ALT5 Sigma (NASDAQ:ALTS) a annoncé sa participation à la prochaine conférence Money20/20 à Las Vegas, qui se tiendra du 27 au 30 octobre 2024. L'entreprise sera présente au stand n° 11713 au Venetian Resort, offrant des démonstrations de produits et des solutions à plus de 12 000 participants. Money20/20 USA est le plus grand rassemblement de l'écosystème monétaire mondial, incluant banques, paiements, technologies, startups et fintech. Le CRO d'ALT5 Sigma, Vay Tham, a souligné l'augmentation des volumes de paiements en cryptomonnaies, plaçant l'entreprise comme un innovateur dans l'écosystème des paiements.
ALT5 Sigma (NASDAQ:ALTS) gab seine Teilnahme an der bevorstehenden Money20/20 Las Vegas-Konferenz vom 27. bis 30. Oktober 2024 bekannt. Das Unternehmen wird am Stand #11713 im The Venetian Resort ausstellen und Produktpräsentationen sowie Lösungen für über 12.000 Teilnehmer anbieten. Money20/20 USA ist das größte Treffen des globalen Geldökosystems, zu dem Banken, Zahlungen, Technologie, Startups und Fintech gehören. Der CRO von ALT5 Sigma, Vay Tham, hob das wachsende Volumen bei Krypto-Zahlungen hervor und positionierte das Unternehmen als Innovator im Zahlungsökosystem.
- Growing volumes reported in crypto payments segment
- None.
LAS VEGAS, NV / ACCESSWIRE / October 23, 2024 / ALT5 Sigma Corporation (NASDAQ:ALTS), a fintech, providing next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, announced their participation in the upcoming Money20/20 Las Vegas conference.
ALT5 will be exhibiting through the 4 days of the conference at the The Venetian Resort, Las Vegas providing product demonstrations, solutions and general information to many of the 12,000+ attendees starting October 27th in booth #11713.
Money20/20 USA is the world's biggest, most influential gathering of the global money ecosystem including banks, payments, tech, startups, retail, fintech, financial services, policy, and more.
"Money20/20 is known for being on the leading edge of innovation in payments, FinTech, and financial services. ALT5 Sigma's growing volumes in the crypto payments space places us in an innovator and leadership position. In our view crypto payments is poised to become a meaningful segment of the payment's ecosystem." said Vay Tham, CRO ALT5 Sigma Corporation.
About ALT5 Sigma
The Company is a unique Nasdaq-listed multidisciplinary organization with a focus on healthcare and fintech. The Company is one of the constituents of the Russell Microcap Index, as of June 28, 2024.
Launched in 2018, ALT5 Sigma Inc. (a wholly-owned subsidiary of ALT5 Sigma Corporation) is a fintech company that provides next generation blockchain-powered technologies to enable a migration to a new global financial paradigm. ALT5 Sigma Inc., through its subsidiaries, offers two main platforms to its customers: "ALT5 Pay" and "ALT5 Prime". ALT5 Sigma Inc. processed over US
ALT5 Pay is a crypto-currency payment gateway that enables registered and approved global merchants to accept and make crypto-currency payments or to integrate the ALT5 Pay payment platform into their application or operations using the plugin with WooCommerce and or ALT5 Pay's checkout widgets and APIs. Merchants have the option to convert to fiat currency (s) automatically or to receive their payment in digital assets.
ALT5 Prime is an electronic over-the-counter trading platform that enables registered and approved customers to buy and sell digital assets. Customers can purchase digital assets with fiat and, equally, can sell digital assets and receive fiat. ALT5 Prime is available through a browser-based access mobile phone application named "ALT5 Pro" that can be downloaded from the Apple App Store, from Google Play, through ALT5 Prime's FIX API, as well as through Broadridge Financial Solutions' NYFIX gateway for approved customers.
Through its biotech activities, the Company is developing innovative, actionable solutions intended to help end the opioid crisis. The Company is dedicated to funding resources toward innovation, technology, and education to find a key resolution to the national opioid epidemic, which is one of the deadliest and most widespread in the nation's history. Its drugs in the clinical trial pipeline have shown promise for their innovative targeting of the causes of pain as a strategic option for physicians averse to exposing patients to addictive opioids.
Forward Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the profitability and prospective growth of ALT5's platforms and business, that may include, but are not limited to, international currency risks, third-party or customer credit risks, liability claims stemming from ALT5's services, and technology challenges for future growth or expansion. This press release also contains statements and links relating to risks that JAN 101 will treat PAD, that JAN 123 will treat CRPS, the timing of the commencement of clinical trials, that the FDA will permit approval through a 505(b)(2) pathway for JAN 123, that upon approval JAN 101 will immediately disrupt the PAD market, and other statements, including words such as "continue", "expect", "intend", "will", "hope", "should", "would", "may", "potential", and other similar expressions. Such statements reflect the Company's current view with respect to future events, are subject to risks and uncertainties, and are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political, and social uncertainties, and contingencies.
Many factors could cause the Company's actual results, performance, or achievements to be materially different from any future results, performance or achievements described in this press release. Such factors could include, among others, those detailed in the Company's periodic reports filed with the Securities and Exchange Commission (the "SEC"). Should one or more of these risks or uncertainties materialize, or should the assumptions set out in the section entitled "Risk Factors" in the Company's filings with the SEC underlying those forward-looking statements prove incorrect, actual results may vary materially from those described herein. These forward-looking statements are made as of the date of this press release and the Company does not intend, and does not assume any obligation, to update these forward-looking statements, except as required by law. The Company cannot assure that such statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. Individuals are cautioned that forward-looking statements are not guarantees of future performance and accordingly investors are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty therein.
Contact Information
Investor Relations
ir@alt5sigma.com
1-800-400-2247
SOURCE: ALT 5 Sigma
View the original press release on accesswire.com
FAQ
When is ALT5 Sigma (ALTS) exhibiting at Money20/20 2024?
What will ALT5 Sigma (ALTS) showcase at Money20/20 2024?
What is ALT5 Sigma's (ALTS) role in the crypto payments space?
